Brief: Viewray Announces 1-Year Outcomes On Mr-Guided Radiation Treatment For Prostate Cancer
23/06/2020 13:08
June 23 (Reuters) - ViewRay Inc VRAY.O :
* VIEWRAY ANNOUNCES 1-YEAR OUTCOMES ON MR-GUIDED RADIATION
TREATMENT FOR PROSTATE CANCER WITHOUT IMPLANTED MARKERS
* VIEWRAY- STUDY SHOWS LOW INCIDENCE OF TOXICITY USING
STEREOTACTIC BODY RADIATION THERAPY WHILE REDUCING POTENTIAL
COMPLICATIONS RELATED TO IMPLANTED MARKERS
Source text for Eikon: ID:nPn8xNknWa
Further company coverage: VRAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viewray
See all newsBrief: ViewRay Announces Commencement Of Nasdaq Delisting Proceedings Common Stock Expected To Begin Trading On The OTC Markets
Press Digest: Wall Street Journal - July 18
U.S. STOCKS ON THE MOVE-Argenx, ViewRay, Ford
ViewRay hits record low on filing for voluntary Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Activision Blizzard, Tesla, Paramount Global